Zobrazeno 1 - 10
of 227
pro vyhledávání: '"S. Bénard"'
Autor:
V Cottin, D Avot, L Lévy-Bachelot, C A Baxter, D R Ramey, L Catella, S Bénard, O Sitbon, S Teal
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0214649 (2019)
Chronic thromboembolic pulmonary hypertension (CTEPH), a rare pulmonary vascular disease, is often misdiagnosed due to nonspecific symptoms. The objective of the study was to develop, refine and validate a case ascertainment algorithm to identify CTE
Externí odkaz:
https://doaj.org/article/9b64ca8c91284487a95e3c1f0ac9189f
Publikováno v:
Journal of Fluid Mechanics. 950
We study swirling electrovortex flows in a cylinder filled with GaInSn metal using axisymmetric and large-scale three-dimensional numerical simulations. In our set-up electrical currents enter and exit the cell symmetrically through wires and the res
Autor:
R Di Blasi, C Thieblemont, C Haioun, L Sackmann Sala, AC Mayaud, P Diez-Andreu, F Bugnard, M Goguillot, J Finzi, L Chillotti, S Bénard
Publikováno v:
Value in Health. 25:S79-S80
Publikováno v:
Value in Health. 25:S458-S459
Publikováno v:
La Revue de Médecine Interne. 43:A444-A445
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Médecine et Maladies Infectieuses Formation. 2:S93
Autor:
Jean-François Korobelnik, Cécile Delcourt, Jules Chassetuillier, Catherine Creuzot-Garcher, Asma Melaine, Anne Lejeune, S Bénard, Laure Dupont-Benjamin
Publikováno v:
Journal of Medical Economics
Journal of Medical Economics, Taylor & Francis, 2021, 24 (1), pp.1087-1097. ⟨10.1080/13696998.2021.1971416⟩
Journal of Medical Economics, 2021, 24 (1), pp.1087-1097. ⟨10.1080/13696998.2021.1971416⟩
Journal of Medical Economics, Taylor & Francis, 2021, 24 (1), pp.1087-1097. ⟨10.1080/13696998.2021.1971416⟩
Journal of Medical Economics, 2021, 24 (1), pp.1087-1097. ⟨10.1080/13696998.2021.1971416⟩
International audience; Aims: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy is standard care for neovascular age-related macular degeneration (nAMD), but the recommended monthly injection regimen is burdensome. Evidence sug
Publikováno v:
Value in Health. 25:S455
Publikováno v:
Value in Health. 25:S462